Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Reason Magazine (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Alex Tabarrok on 'First Doses First'

% of readers think this story is Fact. Add your two cents.


Q&A

The COVID-19 vaccines made by Moderna and Pfizer/BioNTech were developed and brought to market at a blistering pace, but their distribution has been hobbled by poor organization and rigid eligibility rules. The planned rollouts didn’t give local officials and health care workers enough flexibility to adjust to the realities on the ground—or to make tradeoffs between treating as many people as possible and strictly adhering to the guidelines.

Alex Tabarrok, an economist at George Mason University who blogs at Marginal Revolution, has been promoting an idea called “First Doses First,” which the United Kingdom recently adopted. This approach would allocate all available vaccines to be used as first doses, while pushing off second doses for weeks (or even months) until production can catch up. While U.S. regulators have so far resisted the strategy, they recently eased up on strict rules about the timing between doses.

Reason‘s Isaac Reese spoke to Tabarrok in January about the vaccine situation.

Q: You argued that the world’s governments should collectively spend about $100 billion on vaccines. Where does that number come from?

A: The economics of this is actually incredibly simple: The world economy is losing $500 billion to $1 trillion a month. A month. So it’s billions of dollars, invested in vaccines, to save trillions of dollars by accelerating the recovery.

Q: You consulted for the Trump administration, the World Bank, and other foreign governments about how to spur vaccine development. Can you talk about the advice you offered?

A: We initially approached it by thinking about an advanced market commitment, which is what [economist and Nobel laureate Michael] Kremer had used to increase the incentive to produce a pneumococcus vaccine. You set a high price, and then you just wait for firms to jump into the market to try and achieve, like a prize.

We quickly discovered that that might not be optimal in the current situation. The economic costs [of COVID-19] were so high that you wanted a lot of shots on goal, and you even wanted to take some shots with a low probability of success. But if you have a firm with an extremely low probability of success, to pull them into the market requires a very high prize at the end. If you can’t tell which firm is which, that means you need a really big prize for all of the firms, whether they have a high probability of success or a low probability of success.

Q: You’ve been pushing an idea called “First Doses First.” What does that mean?

A: “First Doses First” is pretty simple. The way the clinical trials were designed was that the first dose of the vaccine is given, and then 21 or 28 days later, depending upon whether it’s the Pfizer or the Moderna vaccine, you get the second dose.

It takes the body’s immune system some time to respond to the vaccine and to build up its strength. However, after the first 10 days, but before the second dose was given, what we saw is that the vaccine looks extremely effective. It looks to be 80–90 percent effective [after the first dose]. It’s about 95 percent effective after the second dose.

That means you can give twice as many first doses if, instead of giving a second dose, you give a first dose to somebody else. You can have two people who are protected at an 80 percent efficacy rate, as opposed to one person who’s protected at a 95 percent efficacy rate.

When you push out the first doses faster, you get to herd immunity faster. So the more you spread out the first doses, the slower the transmission rate of the virus is, because now fewer people are getting the disease, and it looks then that fewer people will be transmitting the disease.

This interview has been condensed and edited for style and clarity. For a video version, visit reason.com.



Source: https://reason.com/2021/03/08/alex-tabarrok-on-first-doses-first/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.